Are you Dr. Lendvai?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 75 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
New York, NY 10065Phone+1 212-639-3368Fax+1 646-227-7116
Summary
- Dr. Nikoletta Lendvai, MD is a hematologist in New York, New York. She is currently licensed to practice medicine in New York and New Jersey. She is affiliated with Memorial Sloan Kettering Cancer Center and is an Instructor at Weill Cornell Medical College.
Education & Training
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2004 - 2007
- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 2001 - 2004
- Albert Einstein College of MedicineClass of 2001
Certifications & Licensure
- NJ State Medical License 2007 - 2025
- NY State Medical License 2003 - 2020
Clinical Trials
- Infusional Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma Start of enrollment: 2011 May 09
- MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation Start of enrollment: 2011 Sep 01
Publications & Presentations
PubMed
- Characteristics and outcomes in patients with lenalidomide-refractory multiple myeloma treated with 1-3 prior lines of therapy: Analysis of individual patient-level da...Kwee Yong, Hermann Einsele, Jordan M Schecter, Tito Roccia, William Deraedt
European Journal of Cancer. 2025-01-17 - 1 citationsPatient-reported outcomes following ciltacabtagene autoleucel or standard of care in patients with lenalidomide-refractory multiple myeloma (CARTITUDE-4): results from...Roberto Mina, Anne K Mylin, Hisayuki Yokoyama, Hila Magen, Winfried Alsdorf
The Lancet. Haematology. 2025-01-01 - Real-world treatment patterns and outcomes in relapsed/refractory multiple myeloma (1-3 prior lines): Flatiron database.Binod Dhakal, Hermann Einsele, Jordan M Schecter, William Deraedt, Nikoletta Lendvai
Blood Advances. 2024-10-08